CA2817453A1 - Aqueous solution of ambroxol - Google Patents

Aqueous solution of ambroxol Download PDF

Info

Publication number
CA2817453A1
CA2817453A1 CA2817453A CA2817453A CA2817453A1 CA 2817453 A1 CA2817453 A1 CA 2817453A1 CA 2817453 A CA2817453 A CA 2817453A CA 2817453 A CA2817453 A CA 2817453A CA 2817453 A1 CA2817453 A1 CA 2817453A1
Authority
CA
Canada
Prior art keywords
aqueous solution
ambroxol
solution according
formulation
total content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2817453A
Other languages
English (en)
French (fr)
Inventor
Gianluigi PASSETTI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LECTIO PHARMAENTWICKLUNGS- und VERWERTUNGS GmbH
Original Assignee
LECTIO PHARMAENTWICKLUNGS- und VERWERTUNGS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45094329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2817453(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LECTIO PHARMAENTWICKLUNGS- und VERWERTUNGS GmbH filed Critical LECTIO PHARMAENTWICKLUNGS- und VERWERTUNGS GmbH
Publication of CA2817453A1 publication Critical patent/CA2817453A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
CA2817453A 2010-12-23 2011-12-22 Aqueous solution of ambroxol Abandoned CA2817453A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10196711.5 2010-12-23
EP10196711 2010-12-23
US201061428269P 2010-12-30 2010-12-30
US61/428,269 2010-12-30
PCT/EP2011/073754 WO2012085185A1 (en) 2010-12-23 2011-12-22 Aqueous solution of ambroxol

Publications (1)

Publication Number Publication Date
CA2817453A1 true CA2817453A1 (en) 2012-06-28

Family

ID=45094329

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2817453A Abandoned CA2817453A1 (en) 2010-12-23 2011-12-22 Aqueous solution of ambroxol

Country Status (13)

Country Link
EP (1) EP2654719A1 (pt)
JP (1) JP2014503542A (pt)
KR (1) KR20130140042A (pt)
CN (1) CN103269685A (pt)
AR (1) AR084537A1 (pt)
AU (1) AU2011347257A1 (pt)
BR (1) BR112013012815A2 (pt)
CA (1) CA2817453A1 (pt)
CL (1) CL2013001297A1 (pt)
EA (1) EA201300535A1 (pt)
MX (1) MX2013005500A (pt)
NZ (1) NZ609742A (pt)
WO (1) WO2012085185A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102083621B1 (ko) * 2013-06-13 2020-03-02 한미약품 주식회사 암브록솔 및 레보드로프로피진을 포함하는 안정성이 개선된 경구용 액상 제제
CN103462942B (zh) * 2013-08-20 2016-12-28 湖南赛隆药业有限公司 一种吸入用盐酸氨溴索溶液
CN104316482A (zh) * 2014-08-15 2015-01-28 河北菲尼斯生物技术有限公司 一种盐酸氨溴索颗粒的质量控制方法
CN105287367B (zh) * 2015-10-13 2018-07-10 华润三九（南昌）药业有限公司 一种盐酸氨溴索的口服液体制剂及其制备方法与应用
CN109060473B (zh) * 2018-07-27 2021-03-05 商洛学院 一种盐酸氨溴索杂质对照品的制备方法
CN113995721A (zh) * 2020-07-27 2022-02-01 德国吉麦医疗技术有限公司 一种盐酸氨溴索口腔喷雾溶液及其制备方法
CN112168782A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂的制备方法
CN112168783A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂及制备方法
CN114129510A (zh) * 2021-12-03 2022-03-04 聊城大学 一种复方磺胺注射剂及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
JP2000007561A (ja) * 1998-06-18 2000-01-11 Nissho Corp 塩酸アンブロキソール水溶液製剤
DE19933148A1 (de) 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
US20030171391A1 (en) 2002-01-25 2003-09-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of chronic pain
DE10240802A1 (de) 2002-08-30 2004-04-15 W.L. Gore & Associates Gmbh IR reflektierendes Material
DE10332486A1 (de) 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
KR101232924B1 (ko) * 2003-09-09 2013-02-13 쓰리엠 이노베이티브 프로퍼티즈 컴파니 농축된 항균 조성물 및 방법
US20050075403A1 (en) 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
CN101961307B (zh) * 2010-09-14 2012-07-25 武汉人福药业有限责任公司 治疗呼吸道疾病的口服液及其制备方法

Also Published As

Publication number Publication date
JP2014503542A (ja) 2014-02-13
KR20130140042A (ko) 2013-12-23
CL2013001297A1 (es) 2013-10-11
WO2012085185A1 (en) 2012-06-28
NZ609742A (en) 2015-01-30
CN103269685A (zh) 2013-08-28
MX2013005500A (es) 2013-09-26
BR112013012815A2 (pt) 2016-09-13
AU2011347257A1 (en) 2013-05-23
AR084537A1 (es) 2013-05-22
EP2654719A1 (en) 2013-10-30
EA201300535A1 (ru) 2013-08-30

Similar Documents

Publication Publication Date Title
CA2817453A1 (en) Aqueous solution of ambroxol
JP4856392B2 (ja) 防腐剤及びこれを含有する水性組成物
EP2170362B1 (en) Lyophilized anti-fungal composition
EP2178504B1 (fr) Solution ophtalmique à base de prostaglandines sans conservateur
EP2647380B1 (en) Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
KR100212942B1 (ko) 수성 리스페리돈 제제
EP1713466B1 (en) Antiparasitic composition containing an organic amine salt of closantel
JP6832281B2 (ja) バンコマイシンの水溶液製剤
US20160143911A1 (en) Stable and water soluble pharmaceutical compositions comprising pemetrexed
AU634271B2 (en) Stable solutions of mitomycin c
EP3530289B1 (en) Oral pharmaceutical solutions comprising melatonin
EP2922530B1 (en) Caspofungin acetate formulations
EP1543826B1 (en) Concentrated aqueous solution of ambroxol
US8758782B2 (en) Excipient preservatives and pharmaceutical compositions comprised thereof
EP2804597B1 (en) Aqueous paracetamol composition for injection
AU2011254651B2 (en) Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
ES2507500T3 (es) Composiciones que comprenden ciclohexilaminas y aminoadamantanos
EP2695605A1 (en) Tranexamic acid composition
JP5584336B2 (ja) 防腐剤及びこれを含有する水性組成物
US20080312304A1 (en) Topical compositions containing metronidazole
US20220241284A1 (en) Treatment of cutaneous lupus erythematosus
CA3101093A1 (en) Dantrolene formulations and methods of their use
US20080287514A1 (en) Topical compositions containing metronidazole
WO2014032956A1 (en) Tigecycline formulations
US20080287515A1 (en) Topical compositions containing metronidazole

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20151222